- Published at
- by gurufocus.com
mixed
mixed
News for Paratek Pharmaceuticals, Inc. (PRTK)
- Published at
- by gurufocus.com
positivepositiveParatek Pharmaceuticals Completes Acquisition of Optinose, Creating an Expanded Portfolio of Specialty Therapies
BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company focused on the development and commercializati- Published at
- by gurufocus.com
positivepositiveParatek Pharmaceuticals Completes Acquisition of Optinose (OPTN) | OPTN Stock News
Paratek Pharmaceuticals has successfully finalized its acquisition of Optinose (OPTN), significantly expanding its commercial product line. This deal adds Optin- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositiveSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COOP, MESA on Behalf of Shareholders
PR NewswireNEW YORK, April 9, 2025 NEW YORK, April 9, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following co- Published at
- by gurufocus.com
mixedmixedSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, BECN, OPTN on Behalf of Shareholders
PR NewswireNEW YORK, March 20, 2025 NEW YORK, March 20, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following- Published at
- by benzinga.com
mixedmixedCrude Oil Gains Over 1%; US Weekly Jobless Claims Increase - Benson Hill (NASDAQ:BHIL), Akebia Therapeutics (NASDAQ:AKBA)
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.63% to 42,230.78 whil...- Published at
- by benzinga.com
positivepositiveDow Gains Over 100 Points; Accenture Shares Plunge After Q2 Results - Accenture (NYSE:ACN), Adaptimmune Therapeutics (NASDAQ:ADAP)
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up ...- Published at
- by benzinga.com
mixedmixedUS Stocks Likely To Open Higher As Fed Says Tariff-Induced Inflation Will Be 'Transitory:' Any Pullback In Equities 'Offers An Opportunity,' Says Expert - Accenture (NYSE:ACN), AGM Gr Hldgs (NASDAQ:AG
U.S. stock futures rose on Thursday following the Federal Open Market Committee's decision on Wednesday calling inflation 'transitory'.- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
mixedmixedZai Lab Announces the Inclusion of AUGTYRO® (repotrectinib) for ROS1+ NSCLC and Other Updates in China's National Reimbursement Drug List
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the 2024 National Reimbursement Drug List (NRDL) released by China's National Healthcare Securi- Published at
- by investing.com
mixedmixedZai Lab Announces the Inclusion of AUGTYRO ® (repotrectinib) for ROS1+ NSCLC and Other Updates in China's National Reimbursement Drug List By Investing.com
Zai Lab Announces the Inclusion of AUGTYRO ® (repotrectinib) for ROS1+ NSCLC and Other Updates in China's National Reimbursement Drug List- Published at
- by manilatimes.net
positivepositive- Published at
- by medium.com
mixedmixedAcute Bacterial Skin and Skin Structure Infections Treatment Market: Innovations in Antibiotic…
As per Fortune Business Insights’ report, the acute bacterial skin and skin structure infections treatment market share sector attained a worth of USD 7,270.9 Million in 2018. Forecasts indicate a…- Published at
- by globenewswire.com
positivepositiveParatek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline) Demonstrating No Change in In Vitro Potency Against Indicated Pathogens
Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline) ...- Published at
- by globenewswire.com
mixedmixedGlobal Antibiotic Resistance Market to Exhibit Growth at a CAGR of ~6% by 2030| DelveInsight
The rising challenge of antibiotic-resistant infections is a major factor driving growth in the antibiotic-resistance market. Additionally, the growing...TFXTBH.DET1FX34.SAPRTKMRKD.BAMRK.SNMRK.PAMRK.MXMRKBSX.MXBSX-PABSXBDXBBDX.MXBDXB1SX34.SAABBV34.SAABBV.MXABBV.BAABBV6MK.DE4AB.DE0R19.L0HOY.LVTRSVVTRS.MXVTRSVIA.DESWAVPFED.BAPFECL.SNPFE.SNPFE.MXPFE.DEPFENVSN.MXNVSEFNVSD.BANVSNOVN.SWN1VS34.SAJNJDJNJ3.BADJNJ2.BA0K9E.LTMO.MXTMOSSMXYSSMXFDHR.MXDHRDHER34.SADAP.DECAHD.BABUWA.DEBIO-BBIO6869N.MX6869.T0R2B.L0R0H.L- Published at
- by globenewswire.com
positivepositiveParatek Pharmaceuticals Announces Positive Top-line
Paratek Pharmaceuticals Announces Positive Top-line Efficacy and Safety Data from Post-Marketing Study of NUZYRA® ...- Published at
- by medium.com
mixedmixedAcute Bacterial Skin Infection Treatment Market: Can AI Technology Improve Outcomes?
As per Fortune Business Insights’ report, the acute bacterial skin and skin structure infections treatment market share sector attained a worth of USD 7,270.9 Million in 2018. Forecasts indicate a…- Published at
- by investing.com
mixedmixed